Stonepine Capital Management, LLC Kezar Life Sciences, Inc. Put Options Transaction History
Stonepine Capital Management, LLC
- $124 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KZR
# of Institutions
15Shares Held
14.3MCall Options Held
13.8KPut Options Held
600-
Black Rock Inc. New York, NY830KShares$4.87 Million0.0% of portfolio
-
International Biotechnology Trust PLC London, X0704KShares$4.13 Million0.28% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ3.69KShares$21,6360.0% of portfolio
-
Cutler Group LP2.4KShares$14,0880.0% of portfolio
About Kezar Life Sciences, Inc.
- Ticker KZR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,369,504
- Market Cap $401M
- Description
- Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...